AlphaYouJG
Congress trade
Rep. Josh Gottheimer (D-NJ) bought $1K-$15K of Regeneron Pharmaceuticals, Inc. (REGN) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a purchase of Regeneron Pharmaceuticals, Inc. (REGN) stock worth $1K-$15K in a STOCK Act filing on Sep 16, 2023.
The trade happened on Aug 21, 2023, 26 days before it was made public.
REGN has moved -12.9% since the trade date, from $844.37 to $735.20 (Oct 2, 2026 close).
- Traded
- Aug 21, 2023
- Disclosed
- Sep 16, 2023
- Filing delay
- 26 days
- Price since
- -12.9%
- Source
- STOCK Act disclosure
Other trades in this disclosure (31)
- BuyMSFT$1M-$5MSep 16, 2023
- SellMSFT$1M-$5MSep 16, 2023
- SellMSFT$1M-$5MSep 16, 2023
- BuyMSFT$1M-$5MSep 16, 2023
- SellAAPL$15K-$50KSep 16, 2023
- BuyADYEY$1K-$15KSep 16, 2023
- BuyASAZY$1K-$15KSep 16, 2023
- BuyASAZY$1K-$15KSep 16, 2023
- BuyCHGCY$1K-$15KSep 16, 2023
- BuyDASTY$1K-$15KSep 16, 2023
- SellDXCM$1K-$15KSep 16, 2023
- SellEFX$1K-$15KSep 16, 2023
- BuyETN$1K-$15KSep 16, 2023
- SellFCX$1K-$15KSep 16, 2023
- BuyFOXF$1K-$15KSep 16, 2023
- BuyGOOG$1K-$15KSep 16, 2023
- BuyHSHCY$1K-$15KSep 16, 2023
- BuyLLY$1K-$15KSep 16, 2023
- BuyMA$1K-$15KSep 16, 2023
- BuyMETA$1K-$15KSep 16, 2023
More REGN insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.